FIELD: medicine, pharmaceutics.
SUBSTANCE: invention relates to chemical-pharmaceutical industry, namely to creation of complex medication, which includes mixture of antibiotics: ampicillin or amoxicillin in form of trihydrate or sodium salt and oxacillin sodium salt, in ratio 1-2:1 or sulbactam sodium salt or sulbactam pivoxil and/or potassium clavulanate and/or sodium tazobactam with ratio to sum of antibiotics 0.05-0.7:1. Medication is made in form of tablets, capsules, dry suspensions, syrups and in injection drug form.
EFFECT: medication is intended for therapy of infectious diseases, including those with unidentified antibioticogram and unisolated causative agent, as well as in case of mixed infection.
2 cl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| PHARMACEUTICAL COMPOSITION FOR TREATING BACTERIAL INFECTIONS CAUSED BY THE MAIN PATHOGENS | 2023 |
|
RU2825961C1 |
| PREPARATION FOR TREATING INFECTIOUS DISEASES CAUSED BY MULTIRESISTANT BACTERIA | 2006 |
|
RU2377985C2 |
| REMEDY FOR TREATMENT OF INFECTIOUS DISEASES CAUSED BY MULTIPLE RESISTANT BACTERIA | 2006 |
|
RU2831350C2 |
| INTENDED FOR INJECTION COMPOSITIONS FOR OVERCOMING BETA-LACTAMASE-MEDIATED RESISTANCE TO ANTIBIOTICS WITH APPLICATION OF BETA-LACTAMASE INHIBITOR | 2005 |
|
RU2397768C2 |
| PHARMACEUTICAL COMPOSITIONS CONTAINING BETA-LACTAM ANTIBIOTIC, SULBACTAM AND BETA-LACTAMASE INHIBITOR | 2011 |
|
RU2569059C2 |
| AGENT FOR THE TREATMENT OF INFECTIONS CAUSED BY MULTI-RESISTANT BACTERIA, INCLUDING THOSE PRODUCING CARBAPENEMASE | 2022 |
|
RU2793587C1 |
| COMBINED THERAPEUTIC AGENTS CONTAINING OXAZOLIDINONES-QUINOLONES INTENDED FOR TREATMENT OF BACTERIAL INFECTIONS | 2014 |
|
RU2675847C2 |
| ANTIBACTERIAL COMPOSITIONS | 2013 |
|
RU2646798C2 |
| COMPOSITION, CONTAINING HONEYSUCKLE EXTRACT, AND ANTIBIOTIC, PHARMACEUTICAL SET AND APPLICATION OF HONEYSUCKLE EXTRACT FOR OBTAINING MEDICATIONS | 2011 |
|
RU2571281C2 |
| COMPOSITIONS CONTAINING ANTIBACTERIAL AGENT AND TAZOBACTAM | 2011 |
|
RU2593363C2 |
